[{"AccountsPayableCurrent_0_Q1_USD":8079000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":209000.0,"ShortTermInvestments_0_Q1_USD":144428000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":71597000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":174853000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q1_USD":174851000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":38274000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q1_USD":38071000.0,"RestrictedCashCurrent_0_Q1_USD":194000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":-169000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-16000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-73525000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1144082000.0,"OtherAssetsNoncurrent_0_Q1_USD":997000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1098000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":1188000.0,"InterestReceivable_0_Q1_USD":800000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":16745854.0,"OtherLiabilitiesCurrent_0_Q1_USD":5938000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":68009000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":12644000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1396000.0,"RestrictedCash_0_Q1_USD":1400000.0,"ProceedsFromStockPlans_1_Q1_USD":1330000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1_Q1_USD":97157000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":56851000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1395000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":13691000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":13809000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":90000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-4114000.0,"CapitalUnitsAuthorized_0_Q1_shares":520000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":213127000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q1_USD":212922000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":12644000.0,"AccretionExpense_1_Q1_USD":19000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-5030000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-165000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-42000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":9676000.0,"RestrictedCashNoncurrent_0_Q1_USD":1200000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":13567000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":57659000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":38973000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":23957000.0,"LiabilitiesCurrent_0_Q1_USD":31520000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":299547000.0,"Liabilities_0_Q1_USD":46725000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1888000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-590000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":17038000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.2,"CommonStockValue_0_Q1_USD":6000.0,"CommonStockSharesOutstanding_0_Q1_shares":58940000.0,"CommonStockSharesIssued_0_Q1_shares":58940000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":70203000.0,"AssetsCurrent_0_Q1_USD":229217000.0,"Assets_0_Q1_USD":299547000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":11905581.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":204000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-67044000.0,"ShareBasedCompensation_1_Q1_USD":12644000.0,"NetIncomeLoss_1_Q1_USD":-73509000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":14392000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":20000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-74697000.0,"OperatingExpenses_1_Q1_USD":74697000.0,"InterestPaidNet_1_Q1_USD":17000.0,"IncomeTaxesPaidNet_1_Q1_USD":0.0,"DepreciationAndAmortization_1_Q1_USD":1949000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":61208000.0,"StockholdersEquity_0_Q1_USD":252822000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-891470000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":54442000.0,"ProfitLoss_1_Q1_USD":-73509000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":24277000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1333000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q1_USD":1395000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]